Clinical Case Reports (Jul 2022)

Aggressive prolactinomas responsive to temozolomide treatment: Report of two cases

  • Zahra Davoudi,
  • Mohammad Hallajnejad,
  • Elena Jamali,
  • Mohammadjavad Honarvar

DOI
https://doi.org/10.1002/ccr3.6087
Journal volume & issue
Vol. 10, no. 7
pp. n/a – n/a

Abstract

Read online

Abstract Refractory aggressive prolactinomas are detected after the unresponsiveness to conventional therapies. We report two cases that underwent temozolomide treatment and have been in near‐complete remission ever since. We suggest the pathology techniques for earlier detection and, subsequently, treatment with temozolomide to reduce morbidities and better respond to therapy.

Keywords